Sterility testing results in days, not weeks.
Sapho Bio’s Nucleotide-based platform detects living bacteria and fungi in approximately 2 days, replacing the 14-day standard.
Benefits
The standard hasn't changed. Until now.
Every sterile pharmaceutical product must pass a sterility test before it can be released. For decades, the industry has relied on the same method.
Traditional Method
14 days
Incubate samples for 14 days
Manual visual inspection for turbidity
Drug batches held in quarantine
Capital locked, shelf life consumed
Method introduced decades ago, not designed for modern therapies
Sapho Bio
2 days
Nucleotide-based detection and identification of living organisms
Objective molecular results, not visual inspection
Faster release decisions, less quarantine time
Capital freed, shelf life preserved
Traditional Method
Sapho Bio
WHY NOW
Precision medicines are redefining what "fast enough" means.
Cell therapies, patient-specific products, and biologics with short shelf life cannot afford a 14-day wait. Every hour in quarantine is an hour of usable product life lost — and for some therapies, that window is already narrow.
01
Short Product Shelf Life
Precision therapies often have a shelf life measured in days. Every delay reduces time available for treatment.
02
Idle Inventory
While testing is ongoing, products remain in quarantine. This slows operations and delays time to market.
03
Growing Demand
The precision medicine market is expanding quickly, but testing infrastructure has not kept pace.
04
Legacy Bottleneck
Traditional sterility testing was designed for stable drugs, not time-sensitive therapies.
How it works
Four steps. One day.
Our lab service model means you can start testing immediately, no capital equipment purchase, no lengthy onboarding.
Traditional sterility tests rely on visible growth. It works, but it’s slow.
TECHNOLOGY
We detect what's alive at the molecular level.
How it works
Built by scientists. Run for perfection.
News
